• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Digeranyl bisphosphonate

CAS No. 878143-03-4

Digeranyl bisphosphonate ( —— )

产品货号. M33063 CAS No. 878143-03-4

Digeranyl bisphosphonate (DGBP) 是一种有效的香叶基焦磷酸香叶酯 (GGPP) 合酶抑制剂,抑制 Rac1 的香叶基焦磷酸化。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥3398 有现货
5MG ¥4272 有现货
10MG ¥6848 有现货
25MG ¥11886 有现货
50MG ¥15484 有现货
100MG ¥19125 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Digeranyl bisphosphonate
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Digeranyl bisphosphonate (DGBP) 是一种有效的香叶基焦磷酸香叶酯 (GGPP) 合酶抑制剂,抑制 Rac1 的香叶基焦磷酸化。
  • 产品描述
    Digeranyl bisphosphonate (DGBP) is a potent geranylgeranylpyrophosphate (GGPP) synthase inhibitor, which inhibits geranylgeranylation of Rac1.
  • 体外实验
    Digeranyl bisphosphonate (DGBP) impairs geranylgeranylation. To examine if Digeranyl bisphosphonate modulates Rac1 activity, cells are exposed to vehicle or Digeranyl bisphosphonate. Rac1 activation increases significantly after chrysotile exposure, whereas the activity in Digeranyl bisphosphonate -treated cells is reduced to control levels. Digeranyl bisphosphonate also decreases H2O2 generation in chrysotile-exposed macrophages.
  • 体内实验
    To further evaluate the effect of Digeranyl bisphosphonate (DGBP; 0.2 mg/kg/day) in protecting mice from chrysotile-induced pulmonary fibrosis, the mice are administered vehicle or Digeranyl bisphosphonate subcutaneously in osmotic pumps, and exposed to saline or chrysotile the following day. Mice exposed to saline have normal lung architecture with vehicle and Digeranyl bisphosphonate treatment. Chrysotile-exposed mice that receive vehicle have significant architectural changes in their lung parenchyma and large amounts of collagen deposition, whereas the lungs of the Digeranyl bisphosphonate -treated mice are essentially normal. To investigate the effect of Digeranyl bisphosphonate in Bleomycin-induced fibrosis, osmotic pumps containing either vehicle or Digeranyl bisphosphonate are implanted subcutaneously in WT mice. Mice are exposed to saline or Bleomycin the following day. Digeranyl bisphophonate (0.2 mg/kg/day)-treated mice show significantly less hydroxyproline compared to vehicle-treated mice exposed to Bleomycin.
  • 同义词
    ——
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    Rho
  • 受体
    Rho | Ras
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    878143-03-4
  • 分子量
    536.4
  • 分子式
    C21H34Na4O6P2
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 2 mg/mL (3.73 mM; 超声助溶 ) H2O 中的溶解度 : 2 mg/mL (3.73 mM; 超声助溶)
  • SMILES
    C/C(C)=C\CC/C(C)=C/CC(P([O-])([O-])=O)(P([O-])([O-])=O)C/C=C(C)/CC/C=C(C)\C.[Na+].[Na+].[Na+].[Na+]
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Osborn-Heaford HL, et al. Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis. Free Radic Biol Med. 2015 Sep;86:47-56.?
产品手册
关联产品
  • SAR407899

    SAR407899 是 Rho 激酶抑制剂,可有效抑制内皮素-1 诱导的肾阻力动脉收缩。

  • Zoledronic Acid

    唑来膦酸通过抑制甲羟戊酸途径的酶并防止小 GTP 结合蛋白(如 Ras 和 Rho)的异戊二烯化来诱导破骨细胞凋亡。

  • CCG-257081

    MRTF/SRF-IN-1 (example 41) 是心肌素相关转录因子和血清反应因子 (MRTF/SRF) 的抑制剂。MRTF/SRF-IN-1 可用于预防癌症和纤维化的研究。